Pharmaceutical
| Sun 10 May 2026
Alexandria, May 11 -- Fujian Haixi Pharmaceuticals Co Ltd has submitted a patent application for Heteroaryl Compounds as Multi-target Protein Kinase Inhibitors. This invention was developed by Wang Ruyong, Zhang Fengsen, Lian Xin, Li Hengdong, Gong Xuan, Lin Daqiang, Zheng Zhipeng, Chen Xin, Wu Xueyin, Sun Hongxue, Zhang Yuxuan,..